Literature DB >> 2468204

Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein.

A Sanghvi1, V S Warty, W F Diven, S Todo, T Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468204      PMCID: PMC2904675     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

Authors:  T Ochiai; K Nakajima; M Nagata; T Suzuki; T Asano; T Uematsu; T Goto; S Hori; T Kenmochi; T Nakagoori
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  Differences in the binding, internalization and catabolism of low-density lipoprotein between normal human T and B lymphocytes.

Authors:  A Sanghvi; V Warty
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

4.  IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.

Authors:  A Zeevi; R Duquesnoy; G Eiras; S Todo; L Makowka; T Starzl
Journal:  Surg Res Commun       Date:  1987
  4 in total
  2 in total

1.  Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.

Authors:  Marchella Yasinta; Ruo-Chen Che; Cai-Yu Hu; Xiang-Hui Du; Gui-Xia Ding; Song-Ming Huang; Ying Chen; Ai-Hua Zhang
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 2.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.